Ultragenyx launches gene therapy priced at $3.95 million
Ultragenyx sets the price of its gene therapy for a rare disease at $3.95 million.
Published 2h1 sourceNotableupdated 2h
Lire en français
≈ 20s
The fact
This treatment targets a rare genetic condition, with costs justified by its uniqueness.
Debates over the accessibility of gene therapies intensify due to these high prices.
Click the link to read an article on the topic: